(Q45305061)

11 December 2017

title

Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications (English)

1 reference

11 December 2017

0 references

8

Yvette Bordelon

1 reference

11 December 2017

George Bartzokis

1

1 reference

11 December 2017

Po H Lu

2

1 reference

11 December 2017

Todd A Tishler

3

1 reference

11 December 2017

Sophia M Fong

4

1 reference

11 December 2017

Bolanle Oluwadara

5

1 reference

11 December 2017

J Paul Finn

6

1 reference

11 December 2017

Danny Huang

7

1 reference

11 December 2017

Jim Mintz

9

1 reference

11 December 2017

Susan Perlman

10

1 reference

11 December 2017

publication date

5 May 2007

1 reference

11 December 2017

number of pages

10

1 reference

inferred from page(s)

published in

Neurochemical Research

1 reference

11 December 2017

volume

32

1 reference

11 December 2017

issue

10

1 reference

11 December 2017

page(s)

1655-1664

1 reference

https://scigraph.springernature.com/pub.10.1007/s11064-007-9352-7

11 December 2017

exact match

0 references

cites work

Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11064-007-9352-7

In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-007-9352-7

Morphometric analysis of the prefrontal cortex in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-007-9352-7

Early and progressive accumulation of reactive microglia in the Huntington disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-007-9352-7

The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy.

21 January 2018

1 reference

12 December 2020

Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study

1 reference

12 December 2020

Role of iron in neurodegenerative disorders

1 reference

12 December 2020

Quantitative neuropathological changes in presymptomatic Huntington's disease

1 reference

12 December 2020

Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease

1 reference

12 December 2020

A laminar analysis of the number of neurons, glia, and synapses in the adult cortex (area 17) of adult macaque monkeys.

1 reference

12 December 2020

T1 and T2 of ferritin solutions: effect of loading factor

1 reference

12 December 2020

Nicotine's oxidative and antioxidant properties in CNS.

1 reference

12 December 2020

Cerebral structure on MRI, part II: Specific changes in Alzheimer's and Huntington's diseases

1 reference

12 December 2020

Cellular iron status influences the functional relationship between microglia and oligodendrocytes.

1 reference

12 December 2020

Differential expression of normal and mutant Huntington's disease gene alleles

1 reference

12 December 2020

MR evaluation of age-related increase of brain iron in young adult and older normal males

1 reference

12 December 2020

1 reference

12 December 2020

The relation between brain iron and NMR relaxation times: an in vitro study

1 reference

12 December 2020

Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.

1 reference

12 December 2020

Regionally specific effects of BDNF on oligodendrocytes

1 reference

12 December 2020

Brain structure in preclinical Huntington's disease.

1 reference

12 December 2020

MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects

1 reference

12 December 2020

Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths

1 reference

12 December 2020

Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development

1 reference

12 December 2020

Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group

1 reference

12 December 2020

The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration

1 reference

12 December 2020

Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series

1 reference

12 December 2020

Ferritin levels in microglia depend upon activation: modulation by reactive oxygen species

1 reference

12 December 2020

MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease

1 reference

12 December 2020

Nuclear magnetic resonance relaxation in experimental brain edema: effects of water concentration, protein concentration, and temperature

1 reference

12 December 2020

Cytological and quantitative characteristics of four cerebral commissures in the rhesus monkey

1 reference

12 December 2020

Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level.

1 reference

12 December 2020

Postnatal changes in the number of astrocytes, oligodendrocytes, and microglia in the visual cortex (area 17) of the macaque monkey: a stereological analysis in normal and monocularly deprived animals.

1 reference

12 December 2020

Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores.

1 reference

12 December 2020

Effects of diet and development upon the uptake and distribution of cerebral iron

1 reference

12 December 2020

Development and maturation of central nervous system myelin: Comparison of immunohistochemical localization of proteolipid protein and basic protein in myelin and oligodendrocytes

1 reference

12 December 2020

Frontal lobe volume in patients with Huntington's disease

1 reference

12 December 2020

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules

1 reference

12 December 2020

The distribution of structural neuropathology in pre-clinical Huntington's disease

1 reference

12 December 2020

Electron microscopic immunocytochemical localization of myelin proteolipid protein and myelin basic protein to oligodendrocytes in rat brain during myelination.

1 reference

12 December 2020

Neurobiological bases of age-related cognitive decline in the rhesus monkey.

1 reference

12 December 2020

Relationship of iron to oligodendrocytes and myelination

1 reference

12 December 2020

In vivo MR evaluation of age-related increases in brain iron.

1 reference

12 December 2020

BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION.

1 reference

12 December 2020

Oligodendrocytes, their progenitors and other neuroglial cells in the aging primate cerebral cortex

1 reference

12 December 2020

Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases

1 reference

12 December 2020

Magnetic resonance imaging of brain iron in health and disease

1 reference

12 December 2020

Neuropathological classification of Huntington's disease

1 reference

12 December 2020

Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer's disease.

1 reference

12 December 2020

LINGO-1 negatively regulates myelination by oligodendrocytes

1 reference

12 December 2020

Increased basal ganglia iron levels in Huntington disease

1 reference

12 December 2020

1 reference

12 December 2020

Iron regulation in the brain: histochemical, biochemical, and molecular considerations

1 reference

12 December 2020

Cellular management of iron in the brain.

1 reference

12 December 2020

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

1 reference

12 December 2020

Huntingtin and its role in neuronal degeneration

1 reference

12 December 2020

1 reference

12 December 2020

BDNF overexpression produces a long-term increase in myelin formation in the peripheral nervous system.

1 reference

12 December 2020

The distribution of iron in the brain: a phylogenetic analysis using iron histochemistry.

1 reference

12 December 2020

Histochemical distribution of non-haem iron in the human brain

1 reference

12 December 2020

Iron misregulation in the brain: a primary cause of neurodegenerative disorders

1 reference

12 December 2020

The role of metal ions in oxidative processes and aging.

1 reference

12 December 2020

Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus

1 reference

12 December 2020

Iron in brain function and dysfunction with emphasis on Parkinson's disease

1 reference

12 December 2020

The regional distribution and cellular localization of iron in the rat brain

1 reference

12 December 2020

Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model

1 reference

12 December 2020

Regional studies of myelin proteins in human brain and spinal cord

1 reference

12 December 2020

Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease

1 reference

12 December 2020

Metals in our minds: therapeutic implications for neurodegenerative disorders

1 reference

12 December 2020

Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia

1 reference

12 December 2020

The effect of age on the non-haemin iron in the human brain.

1 reference

12 December 2020

Current status of metals as therapeutic targets in Alzheimer's disease

1 reference

12 December 2020

Intramuscular desferrioxamine in patients with Alzheimer's disease

1 reference

12 December 2020

Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.

1 reference

12 December 2020

Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain.

1 reference

12 December 2020

Iron-enriched oligodendrocytes: A reexamination of their spatial distribution

1 reference

12 December 2020

Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease

1 reference

12 December 2020

In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI.

1 reference

12 December 2020

A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease

1 reference

12 December 2020

Microglial activation correlates with severity in Huntington disease: a clinical and PET study.

1 reference

12 December 2020

In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging

1 reference

12 December 2020

Brain ferritin iron may influence age- and gender-related risks of neurodegeneration.

1 reference

12 December 2020

Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation

1 reference

12 December 2020

Iron, brain ageing and neurodegenerative disorders

1 reference

12 December 2020

10.1007/S11064-007-9352-7

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

1037569647

0 references

1 reference